Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 376 to 390 of 641 results for prescribing

  1. Cabotegravir with rilpivirine for treating HIV-1 (TA757)

    Evidence-based recommendations on cabotegravir (Vocabria) with rilpivirine (Rekambys) for treating HIV-1 in adults. This includes adults with virological suppression (HIV-1 RNA fewer than 50 copies/ml) on a stable antiretroviral regimen, and without any evidence of viral resistance to, and no previous virological failure with, any non-nucleoside reverse transcriptase inhibitors or integrase inhibitors.

    Technology appraisal guidance
    Published
    5 January 2022
    View recommendations

    Sections for TA757

  2. Technology appraisal committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  3. Technology appraisal committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  4. Cladribine for treating active relapsing forms of multiple sclerosis (TA1053)

    Evidence-based recommendations on cladribine (Mavenclad) for treating active relapsing forms of multiple sclerosis in adults.

    Technology appraisal guidance
    Published
    15 April 2025
    View recommendations

    Sections for TA1053

  5. Community pharmacies: promoting health and wellbeing (QS196)

    This quality standard covers how community pharmacies can support the health and wellbeing of the local population. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    28 August 2020
    View quality statements

    Sections for QS196

  6. NICE UK open content licence

    consent of NICE. Current and former NICE logos; the former National Prescribing Centre logo; the Health Development Agency logo; and...

  7. Diabetes in pregnancy: management from preconception to the postnatal period (NG3)

    This guideline covers managing diabetes and its complications in women who are planning pregnancy or are already pregnant. It aims to improve the diagnosis of gestational diabetes and help women with diabetes to self-manage their blood glucose levels before and during pregnancy.

    NICE guideline
    Last updated
    16 December 2020
    View recommendations

    Sections for NG3

  8. Osteoarthritis in over 16s: diagnosis and management (NG226)

    This guideline covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.

    NICE guideline
    Published
    19 October 2022
    View recommendations

    Sections for NG226

  9. Decision-making:- What interventions, systems and processes are effective and cost effective in changing health and social care practitioners' decision-making and ensuring appropriate antimicrobial stewardship?

    point-of-care tests in decision-making is clinically and cost effective when prescribing antimicrobials in children, young people and...

    Research recommendation
    Published
    12 October 2015

  10. Service models for withdrawal interventions: What service models are most effective in supporting withdrawal from medicines associated with dependence and withdrawal symptoms?

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date

    Research recommendation
    Published
    11 May 2022

  11. Cognitive behavioural therapy (CBT) to support withdrawal from benzodiazepines: What is the most effective model of CBT, including timing of CBT, to support withdrawal from benzodiazepines?

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date

    Research recommendation
    Published
    11 May 2022

  12. Oral teicoplanin compared with oral vancomycin or oral fidaxomicin for treating Clostridioides difficile infection: What is the clinical effectiveness, cost effectiveness and safety of oral teicoplanin 100 mg to 200 mg twice a day for 7 to 14 days compared with oral vancomycin or oral fidaxomicin for treating C. difficile infection in adults?

    from guidance Clostridioides difficile infection: antimicrobial prescribing Number NG199 Date issued July 2021 Other details

    Research recommendation
    Published
    12 August 2021

  13. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date

    Research recommendation
    Published
    11 May 2022

  14. Multicomponent withdrawal interventions: What are the key components of an effective multicomponent intervention to support dose reduction during withdrawal of opioids?

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date

    Research recommendation
    Published
    11 May 2022

  15. Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies or interventions to aid withdrawal of gabapentinoids?

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults Number NG215 Date

    Research recommendation
    Published
    11 May 2022